Indication
Exocrine pancreatic insufficiency
Exocrine pancreatic insufficiency is a digestive disorder characterized by the inadequate synthesis, secretion, or intraluminal activity of pancreatic digestive enzymes—predominantly pancreatic lipase—and bicarbonate. Read more about Exocrine pancreatic insufficiency
28 drugs 13 manufacturers
Drugs that treat it
Common Exocrine pancreatic insufficiency therapies.
ULTRASE MT 18 (lipase/protease/amylase (porcine))
ULTRASE MT 20 (lipase/protease/amylase (porcine))
ULTRASE EC (lipase/protease/amylase (porcine))
VIOKASE 8 (lipase/protease/amylase (porcine))
PANCREAZE (lipase/protease/amylase (porcine))
PANCRECARB MS-8 (lipase/protease/amylase (porcine))
VIOKASE 16 (lipase/protease/amylase (porcine))
ULTRASE MT 12 (lipase/protease/amylase (porcine))
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonExocrine pancreatic insufficiency is a digestive disorder characterized by the inadequate synthesis, secretion, or intraluminal activity of pancreatic digestive enzymes—predominantly pancreatic lipase—and bicarbonate.
This deficit disrupts normal gastrointestinal nutrient breakdown, resulting in global maldigestion and secondary malabsorption.
Pathophysiologically driven by parenchymal destruction, ductal obstruction, or postcibal asynchrony, it most frequently occurs in adults with chronic pancreatitis and in pediatric populations with cystic fibrosis, as well as following gastrointestinal surgeries or pancreatic neoplasms.
Clinically, affected individuals present with steatorrhea, abdominal pain, bloating, weight loss, and secondary complications related to fat-soluble vitamin deficiencies and chronic malnutrition.
- nih.gov
Exocrine pancreatic insufficiency is a digestive disorder characterized by the inadequate synthesis, secretion, or intraluminal activity of pancreatic digestive enzymes—predominantly pancreatic lipase—and bicarbonate This deficit disrupts normal gastrointestinal nutrient breakdown, resulting in global maldigestion and secondary malabsorption Pathophysiologically driven by parenchymal destruction, ductal obstruction, or postcibal asynchrony, it most frequently occurs in adults with chronic pancre...
- nih.gov
Exocrine pancreatic insufficiency is a digestive disorder characterized by the inadequate synthesis, secretion, or intraluminal activity of pancreatic digestive enzymes—predominantly pancreatic lipase—and bicarbonate Clinically, affected individuals present with steatorrhea, abdominal pain, bloating, weight loss, and secondary complications related to fat-soluble vitamin deficiencies and chronic malnutrition
- nih.gov
This deficit disrupts normal gastrointestinal nutrient breakdown, resulting in global maldigestion and secondary malabsorption Pathophysiologically driven by parenchymal destruction, ductal obstruction, or postcibal asynchrony, it most frequently occurs in adults with chronic pancreatitis and in pediatric populations with cystic fibrosis, as well as following gastrointestinal surgeries or pancreatic neoplasms
- nih.gov
Clinically, affected individuals present with steatorrhea, abdominal pain, bloating, weight loss, and secondary complications related to fat-soluble vitamin deficiencies and chronic malnutrition
Personalize your experience
Follow Exocrine pancreatic insufficiency and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.